Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation.

作者: S.E. Shoelson , M. Sivaraja , K.P. Williams , P. Hu , J. Schlessinger

DOI: 10.1002/J.1460-2075.1993.TB05714.X

关键词:

摘要: SH2 (src-homology 2) domains define a newly recognized binding motif that mediates the physical association of target phosphotyrosyl proteins with downstream effector enzymes. An example such phosphoprotein-effector coupling is provided by phosphatidylinositol 3-kinase (PI 3-kinase) specific phosphorylation sites within PDGF receptor, c-Src/polyoma virus middle T antigen complex and insulin receptor substrate IRS-1. Notably, phosphoprotein p85 also stimulates an increase in catalytic activity PI p110 subunit, which can be mimicked phosphopeptides corresponding to targeted sites. To investigate how domain activation, we have examined differential effects phosphotyrosine receptor-, IRS-1- c-Src-derived on conformation isolated 3-kinase. Although both activating non-activating bind domain, higher affinity induce qualitatively distinct conformational change as monitored CD NMR spectroscopy. Amide proton exchange protease protection assays further show high affinity, phosphopeptide induces non-local dynamic stabilization. Based these findings propose subunit structure transmitted regulates enzymatic allosteric mechanism.

参考文章(38)
K.R. Auger, C.L. Carpenter, S.E. Shoelson, H Piwnica-Worms, L.C. Cantley, Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro. Journal of Biological Chemistry. ,vol. 267, pp. 5408- 5415 ,(1992) , 10.1016/S0021-9258(18)42781-0
C L Carpenter, B C Duckworth, K R Auger, B Cohen, B S Schaffhausen, L C Cantley, Purification and characterization of phosphoinositide 3-kinase from rat liver. Journal of Biological Chemistry. ,vol. 265, pp. 19704- 19711 ,(1990) , 10.1016/S0021-9258(17)45429-9
J.M. Backer, M.G. Myers, S.E. Shoelson, D.J. Chin, X.J. Sun, M. Miralpeix, P. Hu, B. Margolis, E.Y. Skolnik, J. Schlessinger, Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. The EMBO Journal. ,vol. 11, pp. 3469- 3479 ,(1992) , 10.1002/J.1460-2075.1992.TB05426.X
B J Mayer, P K Jackson, R A Van Etten, D Baltimore, Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Molecular and Cellular Biology. ,vol. 12, pp. 609- 618 ,(1992) , 10.1128/MCB.12.2.609
P Hu, B Margolis, E Y Skolnik, R Lammers, A Ullrich, J Schlessinger, Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Molecular and Cellular Biology. ,vol. 12, pp. 981- 990 ,(1992) , 10.1128/MCB.12.3.981
J A Escobedo, D R Kaplan, W M Kavanaugh, C W Turck, L T Williams, A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Molecular and Cellular Biology. ,vol. 11, pp. 1125- 1132 ,(1991) , 10.1128/MCB.11.2.1125
M Mohammadi, A M Honegger, D Rotin, R Fischer, F Bellot, W Li, C A Dionne, M Jaye, M Rubinstein, J Schlessinger, A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Molecular and Cellular Biology. ,vol. 11, pp. 5068- 5078 ,(1991) , 10.1128/MCB.11.10.5068
B. Margolis, S.G. Rhee, S. Felder, M. Mervic, R. Lyall, A. Levitzki, A. Ullrich, A. Zilberstein, J. Schlessinger, EGF induces tyrosine phosphorylation of phospholipase C-II: A potential mechanism for EGF receptor signaling Cell. ,vol. 57, pp. 1101- 1107 ,(1989) , 10.1016/0092-8674(89)90047-0
M. Mohammadi, C. A. Dionne, W. Li, N. Li, T. Spivak, A. M. Honegger, M. Jaye, J. Schlessinger, Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis Nature. ,vol. 358, pp. 681- 684 ,(1992) , 10.1038/358681A0